Can a lower HIV drug dose keep the virus at bay?
NCT ID NCT02384967
First seen Apr 04, 2026 · Last updated May 15, 2026 · Updated 5 times
Summary
This study looked at whether people with HIV whose virus is already well-controlled can safely lower their daily dose of the drug darunavir from 800 mg to 400 mg. About 100 adults with stable HIV took part. The goal was to see if the lower dose could still keep the virus level under 50 copies per mL after 48 weeks, potentially reducing side effects and treatment costs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Saint Louis
Paris, 75010, France
Conditions
Explore the condition pages connected to this study.